274 related articles for article (PubMed ID: 11745293)
1. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.
Okabayashi T; Yamamoto J; Kosuge T; Shimada K; Yamasaki S; Takayama T; Makuuchi M
Cancer; 2001 Nov; 92(9):2374-83. PubMed ID: 11745293
[TBL] [Abstract][Full Text] [Related]
2. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.
Uenishi T; Nagano H; Marubashi S; Hayashi M; Hirokawa F; Kaibori M; Matsui K; Kubo S
J Surg Oncol; 2014 Aug; 110(2):176-81. PubMed ID: 24760391
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
4. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.
Lang H; Sotiropoulos GC; Frühauf NR; Dömland M; Paul A; Kind EM; Malagó M; Broelsch CE
Ann Surg; 2005 Jan; 241(1):134-43. PubMed ID: 15622001
[TBL] [Abstract][Full Text] [Related]
5. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.
Suzuki S; Sakaguchi T; Yokoi Y; Okamoto K; Kurachi K; Tsuchiya Y; Okumura T; Konno H; Baba S; Nakamura S
World J Surg; 2002 Jun; 26(6):687-93. PubMed ID: 12053220
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
Ariizumi S; Kotera Y; Katagiri S; Nakano M; Yamamoto M
Ann Surg Oncol; 2012 May; 19(5):1628-36. PubMed ID: 22113592
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
12. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
Li DY; Zhang HB; Yang N; Quan Y; Yang GS
World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
15. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
[No Abstract] [Full Text] [Related]
16. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
17. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
[TBL] [Abstract][Full Text] [Related]
18. Liver resection for intrahepatic cholangiocarcinoma in AJCC‑stage Ⅳ: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification.
Yuan L; Luo X; Lu X; Huang B; Cai Q
Oncol Rep; 2016 Nov; 36(5):2663-2672. PubMed ID: 27666632
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma.
Kawarada Y; Yamagiwa K; Das BC
Am J Surg; 2002 Jun; 183(6):679-85. PubMed ID: 12095601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
